Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Clinical trial NCT06836557 · RECRUITING

Trial details

NCT number: NCT06836557
Sponsor: Vanda Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Gastroparesis Diabetic Gastroparesis Gastroparesis

Start date: 2024-01-09
Primary completion: 2025-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.